Overview

480 Biomedical Sinus Drug Depot

Status:
Completed
Trial end date:
2018-05-18
Target enrollment:
Participant gender:
Summary
This is a Phase I, exploratory safety study of the 480 Biomedical Mometasone Furoate Sinus Drug Depot in adult subjects with chronic sinusitis.
Phase:
Phase 1
Details
Lead Sponsor:
480 Biomedical, Inc.
Lyra Therapeutics
Treatments:
Mometasone Furoate